Annual Screening Tests for a 62-Year-Old Patient
For a 62-year-old average-risk patient, you should perform annual colorectal cancer screening (FIT or colonoscopy if not done in past 10 years), annual mammography for women, and lung cancer screening with low-dose CT if they have at least a 20-pack-year smoking history. 1, 2, 3
Colorectal Cancer Screening
At age 62, this patient falls squarely within the recommended screening window (ages 45-75 years). First-tier options include annual fecal immunochemical test (FIT) or colonoscopy every 10 years 4, 1, 5. The U.S. Multi-Society Task Force designates these as cornerstone screening tests with the strongest evidence 5.
- If the patient has never been screened or last colonoscopy was >10 years ago, offer colonoscopy
- If colonoscopy was performed within 10 years with normal results, annual FIT is appropriate
- Alternative second-tier options include CT colonography every 5 years, FIT-DNA every 3 years, or flexible sigmoidoscopy every 5 years 4, 1
The USPSTF 2021 guidelines strongly recommend continuing screening through age 75 6. The Canadian Task Force similarly recommends screening adults aged 60-74 with FOBT every 2 years or flexible sigmoidoscopy every 10 years 4.
Breast Cancer Screening (Women)
Women aged 62 should receive annual mammography 1, 2. The American Cancer Society 2018 guidelines recommend that women 55 years and older transition to biennial screening OR continue annual screening, with continuation as long as overall health is good and life expectancy exceeds 10 years 1. However, the most practical approach is annual screening at this age.
Clinical breast examination can be performed as part of periodic health examination, though mammography remains the primary screening modality 1.
Lung Cancer Screening
If the patient is a current or former smoker with at least a 20-pack-year history who quit within the past 15 years, perform annual low-dose CT screening 2, 3. This applies to patients aged 50-80 years who are in good health and able to undergo curative surgery if cancer is detected 2, 3.
The American Association for Thoracic Surgery recommends annual screening from age 55-79 years for those with 30 pack-year history, though recent evidence supports starting at age 50 with a 20-pack-year threshold 7, 2.
Key caveat: Do not screen patients with significant comorbidities who cannot tolerate treatment or have life expectancy <10 years 7.
Cervical Cancer Screening (Women)
At age 62, cervical cancer screening should continue every 3-5 years until age 65 1, 2, 3. Specifically:
- If using Pap test plus HPV co-testing: every 5 years (preferred) 1
- If using Pap test alone: every 3 years (acceptable) 1
Screening can be discontinued at age 65 if the patient has had adequate prior screening (3 consecutive negative Pap tests or 2 consecutive negative HPV/Pap co-tests within the past 10 years, with the most recent test within 5 years) 1, 3.
Women who have had total hysterectomy with cervix removal (unless for cervical cancer) do not require screening 8.
Prostate Cancer Screening (Men)
For men aged 62, prostate cancer screening with PSA and digital rectal examination is not routinely recommended 3. The USPSTF recommends that men aged 55-69 engage in shared decision-making about PSA screening, but for men 70 and older (including those approaching this age), routine screening is not recommended 3.
If the patient desires screening and has life expectancy >10 years, annual PSA and DRE can be offered after informed discussion of benefits and harms 9, 10, 1.
Additional Screening Considerations
Cardiovascular risk assessment should be performed, including:
- Blood pressure measurement
- Lipid panel for dyslipidemia screening
- Diabetes screening (hemoglobin A1c or fasting glucose)
- Calculate 10-year ASCVD risk score to guide statin therapy 2
Osteoporosis screening for women should begin at age 65, so this can be deferred for 3 more years unless risk factors are present 2.
Routine screening should also include:
- Depression and anxiety screening
- Substance use disorder screening
- HIV screening (if not previously tested or at ongoing risk)
- Hepatitis C screening (one-time for all adults born 1945-1965) 2
Common Pitfalls to Avoid
Do not perform annual comprehensive metabolic panels or complete blood counts in asymptomatic patients without specific indications—general health checks show no mortality benefit 11
Do not continue cervical cancer screening past age 65 in women with adequate prior negative screening 1, 3
Do not screen for lung cancer in never-smokers or those with <20 pack-year history—harms outweigh benefits 2, 3
Do not use single-sample FOBT collected during digital rectal examination—this is inadequate for colorectal cancer screening 4, 1